Descripción de negocio
The Siegfried Group is a global life sciences company with facilities located in Switzerland, the USA, Malta, China, Germany and France. Siegfried is active in primary and secondary drug manufacturing. The company develops and manufactures active pharmaceutical ingredients for pharmaceutical clients with R& D programs, related intermediates and controlled substances. Siegfried also offers development and production of finished dosage forms, including sterile fillings.
Consejo de gestión & Consejo de supervisión
| CEO |
| Marcel Imwinkelried |
| Consejo de gestión |
| Reto Suter, Henrik Krüpper, Dr. Jürgen Roos, Marianne Späne, Irene Wosgien |
| Consejo de supervisión |
| Dr. Andreas Casutt, Dr. Martin Schmid, Alexandra Brand, Wolfram Carius, Elodie Carr-Cingari, Beat Walti, Isabelle Welton |
Datos de la empresa
| Nombre: |
Siegfried Holding AG |
| Dirección: |
Untere Brühlstraße 4,CH-4800 Zofingen |
| Teléfono: |
+41-62-746-1111 |
| Fax: |
+41-62-746-1202 |
| E-mail: |
info@siegfried.ch
|
| Internet: |
www.siegfried.ch |
| Industria: |
Commodities |
| Sector: |
Chemicals |
| Subsector: |
- |
| Fin del año financiero: |
31/12 |
| Acciones de libre circulación: |
75.10% |
| Fecha de OPI: |
- |
Relación con inversores
| Nombre: |
Reto Suter |
| IR teléfono: |
+41-62-746-15-35 |
| IR-fax: |
- |
| IR e-mail: |
reto.suter@siegfried.ch
|
